Zhu Xiaofei, Zhou Ziyuan, Pan Xiaxia
Department of Infectious Diseases, Hangzhou Ninth People's Hospital, Hangzhou, China.
State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Front Microbiol. 2024 Mar 14;15:1342356. doi: 10.3389/fmicb.2024.1342356. eCollection 2024.
INTRODUCTION: The gut-liver axis has emerged as a focal point in chronic liver disorders, prompting more research into the role of the gut microbiota in liver cirrhosis. In individuals with liver cirrhosis, changes in the structure and function of the gut microbiota are closely tied to clinical prognosis. However, there is a scarcity of bibliometric evaluations conducted in this particular field. METHODS: This study is aiming to conduct a complete analysis of the knowledge structure and centers pertaining to gut microbiota in liver cirrhosis using bibliometric methods. Publications on gut microbiota and liver cirrhosis from 2001 to 2023 are sourced from the Web of Science Core Collection. For the bibliometric analysis, we employ VOSviewer, CiteSpace, and the R package "bibliometrix". RESULTS: Our study encompasses a comprehensive collection of 3109 articles originating from 96 countries, with notable contributions from leading nations such as the United States and China. The quantity of publications concerning the gut microbiota of liver cirrhosis rises annually. The University of California San Diego, Virginia Commonwealth University, Zhejiang University are the primary research institutions. World Journal of Gastroenterology publishes the most papers in this field, while hepatology is the most frequently co-cited journal. These publications come from a total of 15,965 authors, and the most prolific authors are Bajaj Jasmohan S., Schnabl Bernd and Gillevet Patrick M., while the most co-cited authors are Bajaj Jasmohan S., Younossi Zobair M., and Reiner Wiest. In addition, "dysbiosis", "gut microbiota", "intestinal barrier", "fecal microbiota transplantation", and "complement-system" are the primary keywords of research trends in recent years. DISCUSSION: This study offering a comprehensive insight into the research dynamics surrounding gut microbiota in patients with liver cirrhosis. It delineates the current research frontiers and hotspots, serving as a valuable guide for scholars.
引言:肠-肝轴已成为慢性肝病的一个焦点,促使人们对肠道微生物群在肝硬化中的作用进行更多研究。在肝硬化患者中,肠道微生物群的结构和功能变化与临床预后密切相关。然而,在这一特定领域进行的文献计量评估却很少。 方法:本研究旨在运用文献计量方法,对肝硬化中肠道微生物群的知识结构和研究中心进行全面分析。2001年至2023年关于肠道微生物群和肝硬化的出版物来源于科学网核心合集。对于文献计量分析,我们使用VOSviewer、CiteSpace和R包“bibliometrix”。 结果:我们的研究全面收集了来自96个国家的3109篇文章,美国和中国等主要国家贡献显著。关于肝硬化肠道微生物群的出版物数量逐年上升。加利福尼亚大学圣地亚哥分校、弗吉尼亚联邦大学、浙江大学是主要研究机构。《世界胃肠病学杂志》在该领域发表的论文最多,而《肝脏病学》是被引用最多的期刊。这些出版物共有15965位作者,发文量最多的作者是巴贾杰·贾斯莫汉·S、施纳布尔·伯恩德和吉勒维特·帕特里克·M,而被引用最多的作者是巴贾杰·贾斯莫汉·S、尤诺西·佐拜尔·M和赖纳·维斯特。此外,“生态失调”“肠道微生物群”“肠屏障”“粪便微生物群移植”和“补体系统”是近年来研究趋势的主要关键词。 讨论:本研究全面深入地了解了肝硬化患者肠道微生物群的研究动态。它描绘了当前的研究前沿和热点,为学者提供了有价值的指导。
Front Endocrinol (Lausanne). 2023
World J Gastroenterol. 2022-9-7
World J Gastroenterol. 2023-6-28
Front Med (Lausanne). 2024-5-22
Medicine (Baltimore). 2024-7-12
Front Endocrinol (Lausanne). 2025-4-1
Front Med (Lausanne). 2025-1-31
Front Neurol. 2025-1-22
Front Cell Infect Microbiol. 2023
Front Immunol. 2022